Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

178 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Validation of prognostic factors and survival of patients with multiple myeloma in a real-life autologous stem cell transplantation setting: a Swiss single centre experience.
Samaras P, Blickenstorfer M, Haile SR, Siciliano RD, Petrausch U, Mischo A, Zweifel M, Honegger H, Schanz U, Stussi G, Taverna C, Bauer S, Knuth A, Stenner-Liewen F, Renner C. Samaras P, et al. Among authors: honegger h. Swiss Med Wkly. 2011 May 31;141:w13203. doi: 10.4414/smw.2011.13203. eCollection 2011. Swiss Med Wkly. 2011. PMID: 21630163 Free article.
Prognostic factors for survival in lymphoma patients after autologous stem cell transplantation.
Samaras P, Zardavas D, Petrausch U, Buset EM, Haile SR, Honegger H, Siciliano RD, Schanz U, Mischo A, Schäfer NG, Taverna C, Knuth A, Stahel R, Renner C, Stenner-Liewen F. Samaras P, et al. Among authors: honegger h. Swiss Med Wkly. 2013 May 7;143:w13791. doi: 10.4414/smw.2013.13791. eCollection 2013. Swiss Med Wkly. 2013. PMID: 23740138 Free article. No abstract available.
Pegfilgrastim reduces the length of hospitalization and the time to engraftment in multiple myeloma patients treated with melphalan 200 and auto-SCT compared with filgrastim.
Samaras P, Blickenstorfer M, Siciliano RD, Haile SR, Buset EM, Petrausch U, Mischo A, Honegger H, Schanz U, Stussi G, Stahel RA, Knuth A, Stenner-Liewen F, Renner C. Samaras P, et al. Among authors: honegger h. Ann Hematol. 2011 Jan;90(1):89-94. doi: 10.1007/s00277-010-1036-8. Epub 2010 Aug 13. Ann Hematol. 2011. PMID: 20706722
Phase II study of capecitabine and oxaliplatin in first- and second-line treatment of advanced or metastatic colorectal cancer.
Borner MM, Dietrich D, Stupp R, Morant R, Honegger H, Wernli M, Herrmann R, Pestalozzi BC, Saletti P, Hanselmann S, Müller S, Brauchli P, Castiglione-Gertsch M, Goldhirsch A, Roth AD. Borner MM, et al. Among authors: honegger h. J Clin Oncol. 2002 Apr 1;20(7):1759-66. doi: 10.1200/JCO.2002.07.087. J Clin Oncol. 2002. PMID: 11919232 Clinical Trial.
A prospective study of risk-adapted therapy for large cell non-Hodgkin's lymphoma with VACOP-B followed by high-dose CBV and autologous progenitor cell transplantation for high-risk patients in remission.
Stahel RA, Jost LM, Kroner T, Dommann-Scherrer C, Maurer R, Glanzmann C, Jacky E, Pichert G, Pestalozzi B, Marincek B, Sauter C, Honegger H. Stahel RA, et al. Among authors: honegger h. Br J Haematol. 1999 Mar;104(4):763-9. doi: 10.1046/j.1365-2141.1999.01263.x. Br J Haematol. 1999. PMID: 10192438 Free article.
178 results